ArticleBMC infectious diseases2021

Provider perspectives on the acceptability and tolerability of dolutegravir-based anti-retroviral therapy after national roll-out in Uganda: a qualitative study.

Henry Zakumumpa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.